DENVER (Ivanhoe Newswire) — A new study may help scientists unlock a medical mystery. Researchers have found that rheumatoid arthritis patients seem to have protection from developing Alzheimer’s disease. The scientific link between the two may help researchers develop a new treatment for Alzheimer’s.
Looking at pictures is just one way Bob and Donna Otten cope, after Bob was diagnosed with Alzheimer’s disease four years ago. While looking through old photos, Donna explained “It’ll help him recall what we saw, because he won’t remember the trip all that well.”
A new study from the University of Colorado may change that. “A protein that is released during rheumatoid arthritis into the blood seems to get into the brain and prevent Alzheimer’s disease from getting hold.” Dr. Huntington Potter, professor of Neurology at the University of Colorado told Ivanhoe.
The protective protein known as GMCSF is also an ingredient in the FDA approved drug leukine which is used to treat leukemia patients.
“This drug is very special because it seems to not only get rid of amyloid deposits in the brain but promotes the growth of new neuronal processes and protects neurons from damage and death.” Said Dr. Potter.
The drug was studied in mice and found to be effective at halting Alzheimer’s disease. Human trials are next.
For those with a family history of Alzheimer’s, like the Ottens, the discovery could be life-saving for future generations.
University of Colorado researchers will continue to study this new drug as a treatment for Alzheimer’s but say definitive results are still a few years away. MORE.
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas, email@example.com.